Intuitive Surgical (NASDAQ:ISRG) Posts Earnings Results, Beats Estimates By $0.46 EPS

Intuitive Surgical (NASDAQ:ISRG) posted its quarterly earnings data on Wednesday. The medical equipment provider reported $3.58 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.12 by $0.46, MarketWatch Earnings reports. Intuitive Surgical had a net margin of 24.45% and a return on equity of 12.08%. During the same quarter in the previous year, the company posted $3.48 earnings per share.

Shares of ISRG opened at $744.08 on Friday. Intuitive Surgical has a twelve month low of $360.50 and a twelve month high of $826.81. The firm’s fifty day simple moving average is $792.68 and its 200-day simple moving average is $722.79. The firm has a market capitalization of $87.47 billion, a price-to-earnings ratio of 84.75, a PEG ratio of 8.96 and a beta of 0.98.

A number of equities analysts recently weighed in on the stock. Morgan Stanley cut shares of Intuitive Surgical from an “overweight” rating to an “equal weight” rating and set a $780.00 price objective for the company. in a research report on Tuesday, December 15th. They noted that the move was a valuation call. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $841.00 to $879.00 and gave the stock an “overweight” rating in a research report on Friday. Oppenheimer increased their price objective on shares of Intuitive Surgical from $365.00 to $410.00 and gave the stock an “underperform” rating in a research report on Friday. They noted that the move was a valuation call. BTIG Research reaffirmed a “hold” rating on shares of Intuitive Surgical in a research report on Thursday, October 15th. Finally, Stifel Nicolaus increased their target price on shares of Intuitive Surgical from $725.00 to $815.00 and gave the stock a “buy” rating in a report on Friday, October 16th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have assigned a buy rating to the company. The company has an average rating of “Hold” and an average target price of $736.06.

In other news, CFO Marshall Mohr sold 6,000 shares of the firm’s stock in a transaction on Monday, October 26th. The shares were sold at an average price of $715.28, for a total value of $4,291,680.00. Following the sale, the chief financial officer now directly owns 20,673 shares in the company, valued at approximately $14,786,983.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Gary S. Guthart sold 11,114 shares of the firm’s stock in a transaction on Tuesday, December 8th. The shares were sold at an average price of $761.76, for a total transaction of $8,466,200.64. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc, together with its subsidiaries, designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

See Also: What is a Swap?